You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 20, 2024

Investigational Drug Information for AZD9833


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for AZD9833?

AZD9833 is an investigational drug.

There have been 15 clinical trials for AZD9833. The most recent clinical trial was a Phase 1 trial, which was initiated on January 28th 2021.

The most common disease conditions in clinical trials are Breast Neoplasms, Liver Diseases, and Disease Progression. The leading clinical trial sponsors are AstraZeneca, Quotient Sciences, and Parexel.

There are two US patents protecting this investigational drug and fifty-two international patents.

Recent Clinical Trials for AZD9833
TitleSponsorPhase
A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid TumorsAstraZenecaPhase 1/Phase 2
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Austrian Breast and Colorectal Cancer Study Group (ABCSG)Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)AstraZenecaPhase 3

See all AZD9833 clinical trials

Clinical Trial Summary for AZD9833

Top disease conditions for AZD9833
Top clinical trial sponsors for AZD9833

See all AZD9833 clinical trials

International Patents for AZD9833

Drugname Country Document Number Estimated Expiration Related US Patent
AZD9833 Argentina AR109951 2036-10-24 ⤷  Sign Up
AZD9833 Australia AU2017349797 2036-10-24 ⤷  Sign Up
AZD9833 Brazil BR112019007393 2036-10-24 ⤷  Sign Up
AZD9833 Canada CA3040040 2036-10-24 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.